Your Trusted Guard Against Acid Peptic Disorders
When acid builds up and causes intense burning, reflux, or ulceration, you need targeted, fast relief. RIPEN IV Injection delivers just that – a potent dose of Pantoprazole 40 mg, administered intravenously for immediate control of gastric acid production.
Formulated for critical care and rapid symptom resolution, RIPEN IV is ideal for managing GERD, NSAID-induced ulcers, duodenal and gastric ulcers, and reflux oesophagitis, especially in hospitalized or non-oral patients.
How RIPEN IV Works
- Pantoprazole is a proton pump inhibitor (PPI) that binds specifically to H+/K+-ATPase enzymes in the stomach lining to block acid secretion at its root.
- More stable across neutral to moderate acidic pH, offering sustained efficacy
- Enhances the effectiveness of antibiotics in eradicating H. pylori
- Minimal drug interaction profile among PPIs – safe and dependable
Effective In:
- Reflux Oesophagitis
- Duodenal & Gastric Ulcers
- GERD (Gastroesophageal Reflux Disease)
- NSAID-induced Ulcers
- Non-Ulcerative Dyspepsia
- Acid-related stress conditions in ICU patients
Key Benefits of RIPEN IV Injection
- Rapid acid suppression in emergency and ICU settings
- Helps heal erosive esophagitis and prevent ulcer recurrence
- Improves outcomes in antibiotic therapy for H. pylori
- Ideal for patients unable to take oral medications
- Reliable, long-lasting acid control
Why Choose RIPEN IV Injection?
Formulated by Riva Kenko Pharma, RIPEN IV provides trusted support when oral options are not viable or fast enough. Its high stability and specific binding mechanism make it a preferred PPI in critical care and gastroenterology settings.
If you’re treating patients with acute acid reflux, GI ulcers, or post-operative acid stress, RIPEN IV delivers dependable, hospital-grade acid control.
Reviews
There are no reviews yet.